PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of molmedLink to Publisher's site
 
Mol Med. 1998 August; 4(8): 525–553.
PMCID: PMC2230400

Frequent N addition and clonal relatedness among immunoglobulin lambda light chains expressed in rheumatoid arthritis synovia and PBL, and the influence of V lambda gene segment utilization on CDR3 length.

Abstract

BACKGROUND: In rheumatoid arthritis (RA), B-lineage cells in the synovial membrane secrete large amounts of immunoglobulin that contribute to tissue destruction. The CDR3 of an immunoglobulin light chain is formed by rearrangements of VL and JL gene segments. Addition of non-germline-encoded (N) nucleotides at V(D)J joins by the enzyme terminal deoxynucleotidyl transferase (TdT) enhances antibody diversity. TdT was previously thought to be active in B cells only during heavy chain rearrangement, but we and others reported unexpectedly high levels of N addition in kappa light chains. We also found clonally related kappa chains bearing unusually long CDR3 intervals in RA synovium, suggesting oligoclonal expansion of a set of atypical B lymphocytes. In this study, we analyzed lambda light chain expression to determine if N addition occurs throughout immunoglobulin gene rearrangement and to compare CDR3 lengths of lambda and kappa light chains in RA patients and normal individuals. MATERIALS AND METHODS: Reverse transcription-polymerase chain reaction (RT-PCR) amplification of V lambda III transcripts was performed on RA synovia and peripheral blood lymphocytes (PBL) and normal PBL for which kappa repertoires were previously analyzed. Representative lambda + PCR products were cloned and sequenced. RESULTS: Analysis of 161 cDNA clones revealed that N addition occurs in lambda light chains of RA patients and normal controls. The lambda light chain repertoires in RA were enriched for long CDR3 intervals. In both RA and controls, CDR3 lengths were strongly influenced by which V lambda gene segment was present in the rearrangement. Five sets of clonally related sequences were found in RA synovia and PBL; one set was found in normal PBL. CONCLUSIONS: In humans, unlike mice, N addition enhances antibody diversity at all stages of immunoglobulin assembly, and the structural diversity of lambda CDR3 intervals is greater than that of kappa light chains. Clonally related V lambda gene segments in RA support an antigen-driven B-cell response.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (5.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Zvaifler NJ. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol. 1973;16(0):265–336. [PubMed]
  • Arend WP. The pathophysiology and treatment of rheumatoid arthritis. Arthritis Rheum. 1997 Apr;40(4):595–597. [PubMed]
  • Smiley JD, Sachs C, Ziff M. In vitro synthesis of immunoglobulin by rheumatoid synovial membrane. J Clin Invest. 1968 Mar;47(3):624–632. [PMC free article] [PubMed]
  • Dreyer WJ, Bennett JC. The molecular basis of antibody formation: a paradox. Proc Natl Acad Sci U S A. 1965 Sep;54(3):864–869. [PubMed]
  • Sanz I. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J Immunol. 1991 Sep 1;147(5):1720–1729. [PubMed]
  • Tonegawa S. Somatic generation of antibody diversity. Nature. 1983 Apr 14;302(5909):575–581. [PubMed]
  • Desiderio SV, Yancopoulos GD, Paskind M, Thomas E, Boss MA, Landau N, Alt FW, Baltimore D. Insertion of N regions into heavy-chain genes is correlated with expression of terminal deoxytransferase in B cells. Nature. 1984 Oct 25;311(5988):752–755. [PubMed]
  • Klein U, Küppers R, Rajewsky K. Human IgM+IgD+ B cells, the major B cell subset in the peripheral blood, express V kappa genes with no or little somatic mutation throughout life. Eur J Immunol. 1993 Dec;23(12):3272–3277. [PubMed]
  • Weber JC, Blaison G, Martin T, Knapp AM, Pasquali JL. Evidence that the V kappa III gene usage is nonstochastic in both adult and newborn peripheral B cells and that peripheral CD5+ adult B cells are oligoclonal. J Clin Invest. 1994 May;93(5):2093–2105. [PMC free article] [PubMed]
  • Klein R, Jaenichen R, Zachau HG. Expressed human immunoglobulin kappa genes and their hypermutation. Eur J Immunol. 1993 Dec;23(12):3248–3262. [PubMed]
  • Victor KD, Capra JD. An apparently common mechanism of generating antibody diversity: length variation of the VL-JL junction. Mol Immunol. 1994 Jan;31(1):39–46. [PubMed]
  • Bridges SL, Jr, Lee SK, Johnson ML, Lavelle JC, Fowler PG, Koopman WJ, Schroeder HW., Jr Somatic mutation and CDR3 lengths of immunoglobulin kappa light chains expressed in patients with rheumatoid arthritis and in normal individuals. J Clin Invest. 1995 Aug;96(2):831–841. [PMC free article] [PubMed]
  • Lee SK, Bridges SL, Jr, Koopman WJ, Schroeder HW., Jr The immunoglobulin kappa light chain repertoire expressed in the synovium of a patient with rheumatoid arthritis. Arthritis Rheum. 1992 Aug;35(8):905–913. [PubMed]
  • Martin T, Blaison G, Levallois H, Pasquali JL. Molecular analysis of the V kappa III-J kappa junctional diversity of polyclonal rheumatoid factors during rheumatoid arthritis frequently reveals N addition. Eur J Immunol. 1992 Jul;22(7):1773–1779. [PubMed]
  • Chuchana P, Blancher A, Brockly F, Alexandre D, Lefranc G, Lefranc MP. Definition of the human immunoglobulin variable lambda (IGLV) gene subgroups. Eur J Immunol. 1990 Jun;20(6):1317–1325. [PubMed]
  • Williams SC, Frippiat JP, Tomlinson IM, Ignatovich O, Lefranc MP, Winter G. Sequence and evolution of the human germline V lambda repertoire. J Mol Biol. 1996 Nov 29;264(2):220–232. [PubMed]
  • Kawasaki K, Minoshima S, Nakato E, Shibuya K, Shintani A, Schmeits JL, Wang J, Shimizu N. One-megabase sequence analysis of the human immunoglobulin lambda gene locus. Genome Res. 1997 Mar;7(3):250–261. [PubMed]
  • Bridges SL, Jr, Lavelle JC, Lee SK, Byer S, Schroeder HW., Jr CDR3 fingerprinting of immunoglobulin kappa light chains expressed in rheumatoid arthritis. Evidence of antigenic selection or dysregulation of gene rearrangement in B cells. Ann N Y Acad Sci. 1997 Apr 5;815:423–426. [PubMed]
  • Ermel RW, Kenny TP, Wong A, Solomon A, Chen PP, Robbins DL. Preferential utilization of a novel V lambda 3 gene in monoclonal rheumatoid factors derived from the synovial cells of rheumatoid arthritis patients. Arthritis Rheum. 1994 Jun;37(6):860–868. [PubMed]
  • Ermel RW, Kenny TP, Chen PP, Robbins DL. Molecular analysis of rheumatoid factors derived from rheumatoid synovium suggests an antigen-driven response in inflamed joints. Arthritis Rheum. 1993 Mar;36(3):380–388. [PubMed]
  • Harindranath N, Goldfarb IS, Ikematsu H, Burastero SE, Wilder RL, Notkins AL, Casali P. Complete sequence of the genes encoding the VH and VL regions of low- and high-affinity monoclonal IgM and IgA1 rheumatoid factors produced by CD5+ B cells from a rheumatoid arthritis patient. Int Immunol. 1991 Sep;3(9):865–875. [PubMed]
  • Fang Q, Kannapell CC, Gaskin F, Solomon A, Koopman WJ, Fu SM. Human rheumatoid factors with restrictive specificity for rabbit immunoglobulin G: auto- and multi-reactivity, diverse VH gene segment usage and preferential usage of V lambda IIIb. J Exp Med. 1994 May 1;179(5):1445–1456. [PMC free article] [PubMed]
  • Lee SK, Bridges SL, Jr, Kirkham PM, Koopman WJ, Schroeder HW., Jr Evidence of antigen receptor-influenced oligoclonal B lymphocyte expansion in the synovium of a patient with longstanding rheumatoid arthritis. J Clin Invest. 1994 Jan;93(1):361–370. [PMC free article] [PubMed]
  • Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979 Nov 27;18(24):5294–5299. [PubMed]
  • Daley MD, Peng HQ, Misener V, Liu XY, Chen PP, Siminovitch KA. Molecular analysis of human immunoglobulin V lambda germline genes: subgroups V lambda III and V lambda IV. Mol Immunol. 1992 Dec;29(12):1515–1518. [PubMed]
  • Combriato G, Klobeck HG. V lambda and J lambda-C lambda gene segments of the human immunoglobulin lambda light chain locus are separated by 14 kb and rearrange by a deletion mechanism. Eur J Immunol. 1991 Jun;21(6):1513–1522. [PubMed]
  • Blomberg BB, Glozak MA, Donohoe ME. Regulation of human lambda light chain gene expression. Ann N Y Acad Sci. 1995 Sep 29;764:84–98. [PubMed]
  • English D, Andersen BR. Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods. 1974 Aug;5(3):249–252. [PubMed]
  • Madsen M, Johnsen HE, Hansen PW, Christiansen SE. Isolation of human T and B lymphocytes by E-rosette gradient centrifugation. Characterization of the isolated subpopulations. J Immunol Methods. 1980;33(4):323–336. [PubMed]
  • Frippiat JP, Lefranc MP. Genomic organisation of 34 kb of the human immunoglobulin lambda locus (IGLV): restriction map and sequences of new V lambda III genes. Mol Immunol. 1994 Jun;31(9):657–670. [PubMed]
  • Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463–5467. [PubMed]
  • Elgavish RA, Schroeder HW., Jr SAW: a graphical user interface for the analysis of immunoglobulin variable domain sequences. Biotechniques. 1993 Dec;15(6):1066–1071. [PubMed]
  • Lafaille JJ, DeCloux A, Bonneville M, Takagaki Y, Tonegawa S. Junctional sequences of T cell receptor gamma delta genes: implications for gamma delta T cell lineages and for a novel intermediate of V-(D)-J joining. Cell. 1989 Dec 1;59(5):859–870. [PubMed]
  • Lewis SM. P nucleotide insertions and the resolution of hairpin DNA structures in mammalian cells. Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1332–1336. [PubMed]
  • Frippiat JP, Williams SC, Tomlinson IM, Cook GP, Cherif D, Le Paslier D, Collins JE, Dunham I, Winter G, Lefranc MP. Organization of the human immunoglobulin lambda light-chain locus on chromosome 22q11.2. Hum Mol Genet. 1995 Jun;4(6):983–991. [PubMed]
  • Frippiat JP, Dard P, Marsh S, Winter G, Lefranc MP. Immunoglobulin lambda light chain orphons on human chromosome 8q11.2. Eur J Immunol. 1997 May;27(5):1260–1265. [PubMed]
  • Daley MD, Olee T, Peng HQ, Soto-Gil RW, Chen PP, Siminovitch KA. Molecular characterization of the human immunoglobulin V lambda I germline gene repertoire. Mol Immunol. 1992 Sep;29(9):1031–1042. [PubMed]
  • Williams SC, Winter G. Cloning and sequencing of human immunoglobulin V lambda gene segments. Eur J Immunol. 1993 Jul;23(7):1456–1461. [PubMed]
  • Ch'ang LY, Schell M, Ringelberg C, Weiss DT, Solomon A. Molecular characterization of a human V lambda VIII germline gene. Mol Immunol. 1995 Jan;32(1):49–55. [PubMed]
  • Deftos M, Soto-Gil R, Quan M, Olee T, Chen PP. Utilization of a potentially universal downstream primer in the rapid identification and characterization of V lambda genes from two new human V lambda gene families. Scand J Immunol. 1994 Jan;39(1):95–103. [PubMed]
  • Ch'ang LY, Yen CP, Besl L, Schell M, Solomon A. Identification and characterization of a functional human Ig V lambda VI germline gene. Mol Immunol. 1994 May;31(7):531–536. [PubMed]
  • Ignatovich O, Tomlinson IM, Jones PT, Winter G. The creation of diversity in the human immunoglobulin V(lambda) repertoire. J Mol Biol. 1997 Apr 25;268(1):69–77. [PubMed]
  • Bauer TR, Jr, Blomberg B. The human lambda L chain Ig locus. Recharacterization of JC lambda 6 and identification of a functional JC lambda 7. J Immunol. 1991 Apr 15;146(8):2813–2820. [PubMed]
  • Vasicek TJ, Leder P. Structure and expression of the human immunoglobulin lambda genes. J Exp Med. 1990 Aug 1;172(2):609–620. [PMC free article] [PubMed]
  • Niewold TA, Murphy CL, Weiss DT, Solomon A. Characterization of a light chain product of the human JC lambda 7 gene complex. J Immunol. 1996 Nov 15;157(10):4474–4477. [PubMed]
  • Dariavach P, Lefranc G, Lefranc MP. Human immunoglobulin C lambda 6 gene encodes the Kern+Oz-lambda chain and C lambda 4 and C lambda 5 are pseudogenes. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9074–9078. [PubMed]
  • Udey JA, Blomberg B. Human lambda light chain locus: organization and DNA sequences of three genomic J regions. Immunogenetics. 1987;25(1):63–70. [PubMed]
  • Ishikawa H, Ziff M. Electron microscopic observations of immunoreactive cells in the rheumatoid synovial membrane. Arthritis Rheum. 1976 Jan-Feb;19(1):1–14. [PubMed]
  • Brown KA, Perry ME, Mustafa Y, Wood SK, Crawley M, Taub N, Dumonde DC. The distribution and abnormal morphology of plasma cells in rheumatoid synovium. Scand J Immunol. 1995 May;41(5):509–517. [PubMed]
  • Kelley DE, Perry RP. Transcriptional and posttranscriptional control of immunoglobulin mRNA production during B lymphocyte development. Nucleic Acids Res. 1986 Jul 11;14(13):5431–5447. [PMC free article] [PubMed]
  • Klein U, Küppers R, Rajewsky K. Evidence for a large compartment of IgM-expressing memory B cells in humans. Blood. 1997 Feb 15;89(4):1288–1298. [PubMed]
  • Clausen BE, Bridges SL, Jr, Lavelle JC, Fowler PG, Gay S, Koopman WJ, Schroeder HW., Jr Clonally-related immunoglobulin VH domains and nonrandom use of DH gene segments in rheumatoid arthritis synovium. Mol Med. 1998 Apr;4(4):240–257. [PMC free article] [PubMed]
  • Campbell MJ, Zelenetz AD, Levy S, Levy R. Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. Mol Immunol. 1992 Feb;29(2):193–203. [PubMed]
  • Päbo S, Higuchi RG, Wilson AC. Ancient DNA and the polymerase chain reaction. The emerging field of molecular archaeology. J Biol Chem. 1989 Jun 15;264(17):9709–9712. [PubMed]
  • Päbo S, Irwin DM, Wilson AC. DNA damage promotes jumping between templates during enzymatic amplification. J Biol Chem. 1990 Mar 15;265(8):4718–4721. [PubMed]
  • Tindall KR, Kunkel TA. Fidelity of DNA synthesis by the Thermus aquaticus DNA polymerase. Biochemistry. 1988 Aug 9;27(16):6008–6013. [PubMed]
  • Barnes WM. The fidelity of Taq polymerase catalyzing PCR is improved by an N-terminal deletion. Gene. 1992 Mar 1;112(1):29–35. [PubMed]
  • Kubagawa H, Cooper MD, Carroll AJ, Burrows PD. Light-chain gene expression before heavy-chain gene rearrangement in pre-B cells transformed by Epstein-Barr virus. Proc Natl Acad Sci U S A. 1989 Apr;86(7):2356–2360. [PubMed]
  • Goossens T, Klein U, Küppers R. Frequent occurrence of deletions and duplications during somatic hypermutation: implications for oncogene translocations and heavy chain disease. Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2463–2468. [PubMed]
  • Wilson PC, de Bouteiller O, Liu YJ, Potter K, Banchereau J, Capra JD, Pascual V. Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J Exp Med. 1998 Jan 5;187(1):59–70. [PMC free article] [PubMed]
  • Bridges SL, Jr, Lee SK, Koopman WJ, Schroeder HW., Jr Analysis of immunoglobulin gamma heavy chain expression in synovial tissue of a patient with rheumatoid arthritis. Arthritis Rheum. 1993 May;36(5):631–641. [PubMed]
  • Ruff-Jamison S, Glenney JR., Jr Requirement for both H and L chain V regions, VH and VK joining amino acids, and the unique H chain D region for the high affinity binding of an anti-phosphotyrosine antibody. J Immunol. 1993 Apr 15;150(8 Pt 1):3389–3396. [PubMed]
  • Randen I, Brown D, Thompson KM, Hughes-Jones N, Pascual V, Victor K, Capra JD, Førre O, Natvig JB. Clonally related IgM rheumatoid factors undergo affinity maturation in the rheumatoid synovial tissue. J Immunol. 1992 May 15;148(10):3296–3301. [PubMed]
  • Randen I, Thompson KM, Pascual V, Victor K, Beale D, Coadwell J, Førre O, Capra JD, Natvig JB. Rheumatoid factor V genes from patients with rheumatoid arthritis are diverse and show evidence of an antigen-driven response. Immunol Rev. 1992 Aug;128:49–71. [PubMed]
  • Martin T, Crouzier R, Blaison G, Levallois H, Pasquali JL. A minor group of rheumatoid factors isolated from a patient with rheumatoid arthritis is derived from somatically mutated Vk1 genes further evidence that rheumatoid factors during autoimmune diseases undergo an antigen driven maturation. Autoimmunity. 1993;15(2):163–170. [PubMed]
  • Olee T, Lu EW, Huang DF, Soto-Gil RW, Deftos M, Kozin F, Carson DA, Chen PP. Genetic analysis of self-associating immunoglobulin G rheumatoid factors from two rheumatoid synovia implicates an antigen-driven response. J Exp Med. 1992 Mar 1;175(3):831–842. [PMC free article] [PubMed]
  • Schröder AE, Greiner A, Seyfert C, Berek C. Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):221–225. [PubMed]
  • Bridges SL, Jr, Clausen BE, Lavelle JC, Fowler PG, Koopman WJ, Schroeder HW., Jr Analysis of immunoglobulin gamma heavy chains from rheumatoid arthritis synovium. Evidence of antigen-driven selection. Ann N Y Acad Sci. 1995 Sep 29;764:450–452. [PubMed]
  • McBlane JF, van Gent DC, Ramsden DA, Romeo C, Cuomo CA, Gellert M, Oettinger MA. Cleavage at a V(D)J recombination signal requires only RAG1 and RAG2 proteins and occurs in two steps. Cell. 1995 Nov 3;83(3):387–395. [PubMed]
  • Gellert M. Recent advances in understanding V(D)J recombination. Adv Immunol. 1997;64:39–64. [PubMed]
  • Prak EL, Weigert M. Light chain replacement: a new model for antibody gene rearrangement. J Exp Med. 1995 Aug 1;182(2):541–548. [PMC free article] [PubMed]
  • Chen C, Prak EL, Weigert M. Editing disease-associated autoantibodies. Immunity. 1997 Jan;6(1):97–105. [PubMed]
  • Pelanda R, Schwers S, Sonoda E, Torres RM, Nemazee D, Rajewsky K. Receptor editing in a transgenic mouse model: site, efficiency, and role in B cell tolerance and antibody diversification. Immunity. 1997 Dec;7(6):765–775. [PubMed]
  • Han S, Dillon SR, Zheng B, Shimoda M, Schlissel MS, Kelsoe G. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science. 1997 Oct 10;278(5336):301–305. [PubMed]
  • Papavasiliou F, Casellas R, Suh H, Qin XF, Besmer E, Pelanda R, Nemazee D, Rajewsky K, Nussenzweig MC. V(D)J recombination in mature B cells: a mechanism for altering antibody responses. Science. 1997 Oct 10;278(5336):298–301. [PubMed]
  • Han S, Zheng B, Schatz DG, Spanopoulou E, Kelsoe G. Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells. Science. 1996 Dec 20;274(5295):2094–2097. [PubMed]
  • Ziff M. Relation of cellular infiltration of rheumatoid synovial membrane to its immune response. Arthritis Rheum. 1974 May-Jun;17(3):313–319. [PubMed]
  • Iguchi T, Ziff M. Electron microscopic study of rheumatoid synovial vasculature. Intimate relationship between tall endothelium and lymphoid aggregation. J Clin Invest. 1986 Feb;77(2):355–361. [PMC free article] [PubMed]
  • van Dinther-Janssen AC, Pals ST, Scheper R, Breedveld F, Meijer CJ. Dendritic cells and high endothelial venules in the rheumatoid synovial membrane. J Rheumatol. 1990 Jan;17(1):11–17. [PubMed]
  • Steere AC, Duray PH, Butcher EC. Spirochetal antigens and lymphoid cell surface markers in Lyme synovitis. Comparison with rheumatoid synovium and tonsillar lymphoid tissue. Arthritis Rheum. 1988 Apr;31(4):487–495. [PubMed]
  • Schröder AE, Sieper J, Berek C. Antigen-dependent B cell differentiation in the synovial tissue of a patient with reactive arthritis. Mol Med. 1997 Apr;3(4):260–272. [PMC free article] [PubMed]
  • Kumon I. In situ characterization of mononuclear cell phenotype in intrahepatic lymphoid follicles in patients with chronic viral hepatitis. Gastroenterol Jpn. 1992 Oct;27(5):638–645. [PubMed]
  • Freni MA, Artuso D, Gerken G, Spanti C, Marafioti T, Alessi N, Spadaro A, Ajello A, Ferraù O. Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity. Hepatology. 1995 Aug;22(2):389–394. [PubMed]
  • Mosnier JF, Degott C, Marcellin P, Hénin D, Erlinger S, Benhamou JP. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology. 1993 Mar;17(3):366–371. [PubMed]

Articles from Molecular Medicine are provided here courtesy of The Feinstein Institute for Medical Research at North Shore LIJ